Drugs Made In America Acquisition (DMIIR) Net Cash Flow (2025)
Drugs Made In America Acquisition (DMIIR) reported Net Cash Flow of -$314864.0 for Q4 2025.
Drugs Made In America Acquisition (DMIIR) has 1 years of Net Cash Flow data on file, last reported at -$314864.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 378,972.00 |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | -369,667.00 |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | -72,157.00 |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 165,329.00 |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -16.06 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | -207,911.00 |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 328,760.00 |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | -227,953.00 |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | -173,417.00 |
| 10 | Drugs Made In America Acquisition | - | - | - | -314,864.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -314,864.00 |
| Dec 31, 2025 | -314,864.00 |